Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
NEW ORLEANS, Feb. 23, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 6, 2018 to file lead plaintiff applications in a securities class action lawsuit against MetLife, Inc. (NYSE:MET), if they purchased the Company’s securities between February 27, 2013 and January 29, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
MetLife investors should visit us at https://www.claimsfiler.com/cases/view-metlife-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
MetLife and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On January 29, 2018, MetLife disclosed “a material weakness in internal controls over financial reporting” that caused reserves to be reduced incorrectly relating to outstanding payouts for annuity and pension recipients and that its Q4 earnings release was postponed, with reserves expected to increase by $525 million to $575 million, Q4 earnings to decrease by $135 million to $165 million, and 2017 profits cut by $165 million to $195 million. MetLife also revealed a SEC investigation into the outstanding pension payments matter.
On this news, the price of MetLife’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
